Healthcare

Ekso Bionics Holdings is entering what could be a transformative first half of 2026. The company stands at a critical...

As of February 2026, the two biotech pioneers synonymous with the mRNA-based COVID-19 vaccine rollout, Moderna and BioNTech, face a...

Eli Lilly & Company is currently benefiting from two significant and concurrent developments that bolster its business outlook. These events...

India Globalization Capital (IGC Pharma) is significantly expanding the clinical development of its Alzheimer's drug candidate, IGC-AD1. The company has...

Enochian Biosciences is executing a strategic pivot to become an artificial intelligence-powered biotechnology firm. Through a new oncology collaboration and...

Rockwell Medical is intensifying its efforts to solidify its presence within the competitive U.S. healthcare sector. The company's recent success...

Alpha Pro Tech's business model presents a study in strategic balance, navigating two distinct economic sectors. The company's performance is...

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed clinical trial data...

Biotechnology firm Quanterix has taken a pivotal step toward transforming the diagnosis of Alzheimer's disease. The company has formally submitted...

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which concluded in late...